Adrenomed’s Adrecizumab: the septic shock study that’s passed analysis
Adrenomed’s septic shock study introduces Adrecizumab, a first-in-class antibody targeting Adrenomedullin, to restore and maintain vascular integrity in early septic shock.
Hennigsdorf, Germany, 21 March...
Severe depression treatment and deep brain stimulation
World's largest study of deep brain stimulation in the brain's reward system was conducted providing sustained relief can patients use this as a form...
Tackling loneliness: Vodafone explores if technology makes us more alone
Do you think technology makes us more alone? Discover how multinational telecoms company, Vodafone, launched a new report into the role tech plays in...
Learn how the global urology imaging systems market is to account for almost €428.3...
According to the latest research by the FMI, the global urology imaging systems market is expected to account for over $486.4 million (~€428.3 million),...
Treating ovarian cancer may be achieved with a new class of drugs
According to Manchester University, UK, a new class of drugs, called PARG inhibitors, have the ability of treating ovarian cancer and even stopping cancer...
Fibrinolytic therapy: discover the blood thinning medication
According to research presented at the American College of Cardiology’s 68th Annual Scientific Session, a new blood thinning medication could be effective in fibrinolytic...
World’s first life-saving 3D printed kidney changing the game for surgical operations
At this years SXSW event, the 3D printed kidney took the spotlight, highlighting the technology behind the procedure and demonstrating the future of complex...
Discover the digital health company taking disease management a step further
Executing disease management may be made easy as digital health company, Liva Healthcare, receives €8 million investment from MIG, Santo Venture Capital and Digital...
Understanding human health with genome analysis
Understanding human health has been taken to another level as researchers at the Garvan Institute of Medical Research and UNSW, Australia, have published a...
European Bioinformatics Institute to tackle life threatening diseases
Following a £45 million (~€52.7 million) investment, the European Bioinformatics Institute is one step closer to improving the world’s understanding of genetics and molecular...
From promising ideas to commercially viable digital health solutions
EIT Health considers the challenges and opportunities involved in delivering digital health solutions to the market and into healthcare practice.
EIT Health leverages the expertise...
myLotus: fertility monitoring made easy
myLotus takes the stress (and cost) out of effective fertility monitoring – helping to democratise the fertility journey for all women.
Women are having fewer...
Cancer screening device: detecting cancer from breath
Detecting cancer from breath doesn’t sound possible right? Well, SniffPhone is the new cancer screening device that enables early diagnosis of gastric cancer by...
Let’s talk cognitive evolution, tool development and social complexity
Researchers have discovered proof that parallel development between cognitive evolution, tool development, and social complexity exists.
A study analysed the selective attention processes that determine...
The eccentric marvels of biology: using tweezers to study FUS droplets
Did you know we can use laser ‘tweezers’ to study FUS droplets? Well, according to the University at Buffalo, USA, studying this protein can...
Explore International Women’s Day, with EIT Health’s Ursula Mühle
Introducing Ursula Mühle, Director of Education for EIT Health, who talks barriers, challenges and the gender question, and delves into how International Women’s Day...
A good life longer: Bee Concepts’ vision for the ageing population
Bee Concepts CEO and founder Knut Ruud explains how the company’s innovative solutions are facilitating healthy, active lifestyles for the ageing population.
Today, we live...
Health+Care: the evolution of digital healthcare
CloserStill Media are delighted to announce a new era for Health+Care that will crystallise the education and innovation offering for delegates in the world...
Beating Childhood Cancer: minimising deaths and late effects
SIOP Europe and CCI Europe have the ambitious goal of beating childhood cancer, with the aim of curing more and curing better – towards...
What do you know about the mobile bedside bioprinter that can heal wounds?
Envision a day when a mobile bedside bioprinter filled with a patient’s own cells can be wheeled right next to them to heal wounds...
